These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 24411404

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ, EULAR Sjögren's Task Force.
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [Abstract] [Full Text] [Related]

  • 5. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.
    Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ, EULAR Sjögren's Task Force.
    Ann Rheum Dis; 2011 Jun; 70(6):968-72. PubMed ID: 21345815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How to assess treatment efficacy in Sjögren's syndrome?
    Vissink A, Bootsma H, Kroese FG, Kallenberg CG.
    Curr Opin Rheumatol; 2012 May; 24(3):281-9. PubMed ID: 22450393
    [Abstract] [Full Text] [Related]

  • 12. Clinimetric methods in Sjögren's syndrome.
    Hernández-Molina G, Sánchez-Hernández T.
    Semin Arthritis Rheum; 2013 Jun; 42(6):627-39. PubMed ID: 23352255
    [Abstract] [Full Text] [Related]

  • 13. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M, Brito-Zerón P, Solans R, Camps MT, Casanovas A, Sopeña B, Díaz-López B, Rascón FJ, Qanneta R, Fraile G, Pérez-Alvarez R, Callejas JL, Ripoll M, Pinilla B, Akasbi M, Fonseca E, Canora J, Nadal ME, de la Red G, Fernández-Regal I, Jiménez-Heredia I, Bosch JA, Ayala MD, Morera-Morales L, Maure B, Mera A, Ramentol M, Retamozo S, Kostov B, SS Study Group, Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI).
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [Abstract] [Full Text] [Related]

  • 14. Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.
    Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, Canavan A, Hamburger J, Richards A, Rauz S, Regan M, Gadsby K, Rigby S, Jones A, Mathew R, Mulherin D, Stevenson A, Nightingale P.
    Rheumatology (Oxford); 2007 Dec; 46(12):1845-51. PubMed ID: 18032543
    [Abstract] [Full Text] [Related]

  • 15. The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.
    Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, Canavan A, Hamburger J, Richards A, Regan M, Gadsby K, Rigby S, Jones A, Mathew R, Mulherin D, Stevenson A, Nightingale P, Rauz S, Bowman SJ.
    Rheumatology (Oxford); 2008 Aug; 47(8):1193-8. PubMed ID: 18524804
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate?
    Seror R, Rauz S, Gosset M, Bowman SJ.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3528-3539. PubMed ID: 31236580
    [Abstract] [Full Text] [Related]

  • 19. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
    Cooper C, Wratten S, Williams-Hall R, Bookman AAM, Ndife B, Hueber W, Goswami P.
    Rheumatol Ther; 2022 Dec 02; 9(6):1499-1515. PubMed ID: 36114443
    [Abstract] [Full Text] [Related]

  • 20. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
    Pertovaara M, Korpela M.
    Rheumatology (Oxford); 2014 May 02; 53(5):927-31. PubMed ID: 24464708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.